Using AI to improve dermatology patient care
Optimization of Clinical Workflow in Patients With Various Dermatological Conditions Through Artificial Intelligence
AI Labs Group S.L · NCT06263413
This study is testing whether an AI tool can help dermatologists better prioritize and manage patient care for skin conditions like acne and hair loss, especially during telemedicine visits.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 16 Years and up |
| Sex | All |
| Sponsor | AI Labs Group S.L (industry) |
| Locations | 1 site (Madrid) |
| Trial ID | NCT06263413 on ClinicalTrials.gov |
What this trial studies
This study evaluates the use of artificial intelligence (AI) to optimize clinical workflows for dermatological conditions such as acne, alopecia, and pigmented lesions. By leveraging AI tools, the study aims to enhance diagnostic accuracy and improve patient triage and follow-up processes, particularly in the context of increased telemedicine usage during the COVID-19 pandemic. The Legit.Health tool, developed by AI LABS GROUP S.L., will be assessed for its effectiveness in prioritizing patients based on urgency and optimizing the workload of dermatology professionals.
Who should consider this trial
Good fit: Ideal candidates for this study include adults aged 18 and older with pigmented lesions, active inflammatory acne, or women with androgenetic alopecia.
Not a fit: Patients who are unable or unwilling to comply with the study procedures may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the efficiency of dermatological care and improve patient outcomes through timely and accurate diagnosis.
How similar studies have performed: Other studies have shown promise in using AI for diagnostic purposes in dermatology, indicating that this approach is gaining traction in the field.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18 years or older (16 years for acne). * Patients with pigmented lesions meeting any of the following conditions: * Presenting for the first time with a pigmented lesion. * Previously scheduled for dermoscopy consultation for the first time or for review of pigmented lesions. * Patients with active inflammatory acne. * Women with androgenetic alopecia. Exclusion Criteria: * Patients deemed by the investigator to be unable or unwilling to comply with the study procedures.
Where this trial is running
Madrid
- IDEI Hospital — Madrid, Spain (RECRUITING)
Study contacts
- Principal investigator: Miguel Sánchez-Viera, PhD — IDEI Hospital
- Study coordinator: Miguel Sánchez-Viera, PhD
- Email: sanchez.viera@ideidermatologia.com
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Acne, Acne Vulgaris, Alopecia, Androgenetic, Pigmented Lesions, Pigmented Skin Lesion, Androgenetic alopecia, Pigmented lesions, Artificial Intelligence